The Angels over Boston ALS Therapy conference was a great success. Researchers and clinicians from five countries and the US joined to discuss ALS research.
The conference brought together leading scientists and clinicians from around the world who are dedicated to advancing research that will lead to effective treatments—and ultimately a cure—for Amyotrophic Lateral Sclerosis (ALS), more commonly known as Lou Gehrig’s Disease.
Read the conference wrapup release.
Check out the researchers/clinicians who attended the conference.
Marathon gift
A long time and one of our earliest Angel Fund supporters, Ed Rice, shared this photo from 30 years ago as he presented The Angel Fund’s founder and original Angel, Ginny DelVecchio a special gift.
Ed Rice:”When I ran the 100th Boston Marathon in April of 1996 I became the first individual to have the honor of starting an incredible tradition. When I presented Ginny my special finisher’s medal in the VIP tent after completing the course (see photograph enclosed, as an attachment, below), we (Ginny, Paul and I) all hoped to capitalize on a moment to (1) raise awareness about the so-called “orphan disease” and (2) catapult our little local fund into a significant fund-raising vehicle. Thanks to all of you — and, of course, everyone associated today with The Angel Fund — our dream…is a reality.”
The Angel Fund donates $800,000
(Wakefield, MA)- The Angel Fund for ALS Research has awarded $800,000 to UMass Chan Medical School to accelerate research into amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
The donation supports the work of two recognized leaders in ALS research: Robert H. Brown Jr., DPhil, MD, the Donna M. and Robert J. Manning Chair in Neuroscience and professor of neurology and Daryl Bosco, PhD, the Paul J. Dimare Chair in Neurodegenerative Disease and professor of neurology, along with their research colleagues at UMass Chan. A pioneer in the field of ALS research, Dr. Brown discovered the first gene linked to hereditary ALS and led the first clinical trial for ALS using gene therapy.
The Angel Fund for ALS Research has raised millions of dollars to support scientific research, clinical trials, and collaborative efforts aimed at ending ALS. Since its inception in 1997, the Angel Fund has contributed more than $10 million to ALS research, over $2 million in the last three years.